Exposure-Efficacy Relationship

Exposure-efficacy relationship quantifies therapeutic response dependencies on drug concentration or dose. Efficacy thresholds identify minimum exposures necessary for clinical benefit. Saturation concentrations define maximum achievable efficacy above which further exposure increases produce negligible benefit. Steep exposure-response relationships necessitate precise dose control; shallow relationships permit wider dosing ranges.

Population exposure-efficacy analysis incorporates heterogeneous patient populations identifying covariate effects. Biomarker-driven dosing based on exposure-efficacy relationships optimises therapy outcomes. Regulatory submissions incorporate exposure-efficacy analysis supporting dose recommendations. Post-approval monitoring tracks real-world exposure-efficacy relationships confirming predicted clinical performance. Adaptive dosing strategies adjust doses maintaining therapeutic exposures.